Devex: Q&A: Rajeev Venkayya on why vaccines are a worthy investment
“…The success of vaccines going forward, [Rajeev Venkayya, the president of the Global Vaccine Business Unit at Takeda Pharmaceuticals,] says, requires public and policy support for investments ‘to make sure that we’re driving strong immunization coverage everywhere but also investing in new vaccines for the diseases that should be vaccine preventable,’ he said. … Devex sat down with Venkayya in Geneva at a summit held last month during the World Health Assembly…” (Saldinger, 6/28).